Evidence map›Paper›PMID 34202008›Full record

ArticlePharmaceutics2021

Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane

Eun Suk Son, Xiang Fei, Jin-Ha Yoon, Seung-Yong Seo, Han-Joo Maeng, Sung Hwan Jeong, Yu Chul Kim

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eun Suk SonDepartment of Medicine, Gachon University Gil Medical Center, Incheon 21565, Korea.ORCID 0000-0002-8149-4553
Xiang FeiDepartment of Pharmacy, College of Pharmacy, Gachon University, Incheon 21936, Korea.ORCID 0000-0001-9637-1989
Jin-Ha YoonDepartment of Pharmacy, College of Pharmacy, Gachon University, Incheon 21936, Korea.
Seung-Yong SeoDepartment of Pharmacy, College of Pharmacy, Gachon University, Incheon 21936, Korea.ORCID 0000-0002-2672-4707
Han-Joo MaengDepartment of Pharmacy, College of Pharmacy, Gachon University, Incheon 21936, Korea.
Sung Hwan JeongDepartment of Medicine, Gachon University Gil Medical Center, Incheon 21565, Korea.
Yu Chul KimDepartment of Pharmaceutical Engineering, Inje University, Gimhae 50834, Korea.ORCID 0000-0001-7280-9317
Gachon University · KRGachon University Gil Medical Center · KRInje University · KR

Funding

National Research Foundation of Korea 20191A2C2089867, 2019R1F1A1058103
6 · The paper itself

Abstract

Sulforaphane (SFN), belonging to the isothiocyanate family, has received attention owing to its beneficial activities, including chemopreventive and antifibrotic effects. As sulforaphane

Indexed as

anti-pulmonary fibrosis effectmetabolic stabilitypharmacokineticssulforaphanesulforaphane N-acetylcysteine

Identifiers

PMID34202008
PMCPMC8309207
OpenAlexW3176325004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.